CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,206 | $548.87 | $662K | 327,837 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −757 | $549.59 | $416K | 327,080 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −432 | $550.99 | $238K | 326,648 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −725 | $551.82 | $400K | 325,923 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $552.86 | $88K | 325,763 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $554.30 | $44K | 325,683 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $555.60 | $44K | 325,603 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $557.43 | $134K | 325,363 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $558.60 | $67K | 325,243 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $560.66 | $67K | 325,123 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $562.35 | $22K | 325,083 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $563.88 | $45K | 325,003 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $566.58 | $45K | 324,923 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $569.90 | $137K | 324,683 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $570.70 | $68K | 324,563 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $572.44 | $46K | 324,483 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $574.23 | $23K | 324,443 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 309,410 | ||
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $560.05 | $67K | 333,823 |
Page 26 of 121 · 2,404 trades